Inhibition of type 1 diabetes in filaria-infected non-obese diabetic mice is associated with a T helper type 2 shift and induction of FoxP3+ regulatory T cells

被引:96
|
作者
Hubner, Marc P. [1 ]
Stocker, J. Thomas [2 ]
Mitre, Edward [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA
[2] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA
关键词
autoimmune; diabetes; helminth; immunomodulation; Litomosoides sigmodontis; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRICHURIS-SUIS THERAPY; SCHISTOSOMA-MANSONI; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; COLITIS; CD4(+); INFLAMMATION; MELLITUS; DISEASE;
D O I
10.1111/j.1365-2567.2008.02958.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P>We sought to determine whether Litomosoides sigmodontis, a filarial infection of rodents, protects against type 1 diabetes in non-obese diabetic (NOD) mice. Six-week-old NOD mice were sham-infected or infected with either L3 larvae, adult male worms, or adult female worms. Whereas 82% of uninfected NOD mice developed diabetes by 25 weeks of age, no L. sigmodontis-infected mice developed disease. Although all mice had evidence of ongoing islet cell inflammation by histology, L. sigmodontis-infected mice had greater numbers of total islets and non-infiltrated islets than control mice. Protection against diabetes was associated with a T helper type 2 (Th2) shift, as interleukin-4 (IL-4) and IL-5 release from alpha-CD3/alpha-CD28-stimulated splenocytes was greater in L. sigmodontis-infected mice than in uninfected mice. Increased circulating levels of insulin-specific immunoglobulin G1, showed that this Th2 shift occurs in response to one of the main autoantigens in diabetes. Multicolour flow cytometry studies demonstrated that protection against diabetes in L. sigmodontis-infected NOD mice was associated with significantly increased numbers of splenic CD4(+) CD25(+) FoxP3(+) regulatory T cells. Interestingly, injection of crude worm antigen into NOD mice also resulted in protection against type 1 diabetes, though to a lesser degree than infection with live L. sigmodontis worms. In conclusion, these studies demonstrate that filarial worms can protect against the onset of type 1 diabetes in NOD mice. This protection is associated with a Th2 shift, as demonstrated by cytokine and antibody production, and with an increase in CD4(+) CD25(+) FoxP3(+) regulatory T cells.
引用
收藏
页码:512 / 522
页数:11
相关论文
共 50 条
  • [1] INHIBITION OF TYPE I DIABETES IN FILARIA INFECTED NOD MICE IS ASSOCIATED WITH A TH2 SHIFT AND INDUCTION OF REGULATORY T CELLS
    Huebner, Marc R.
    Torrero, Marina N.
    Larson, David
    Stocker, J. Thomas
    Mitre, Edward
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2008, 79 (06): : 231 - 232
  • [2] Thymically-derived Foxp3+ regulatory T cells are the primary regulators of type 1 diabetes in the non-obese diabetic mouse model
    Holohan, Daniel R.
    Van Gool, Frederic
    Bluestone, Jeffrey A.
    PLOS ONE, 2019, 14 (10):
  • [3] Diabetes in non-obese diabetic mice is not associated with quantitative changes in CD4+ CD25+ Foxp3+ regulatory T cells
    Mellanby, Richard J.
    Thomas, David
    Phillips, Jenny M.
    Cooke, Anne
    IMMUNOLOGY, 2007, 121 (01) : 15 - 28
  • [4] Foxp3+ Regulatory T Cells in Mouse Models of Type 1 Diabetes
    Petzold, Cathleen
    Riewaldt, Julia
    Watts, Deepika
    Sparwasser, Tim
    Schallenberg, Sonja
    Kretschmer, Karsten
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [5] Ras inhibition increases the frequency and function of regulatory T cells and attenuates type-1 diabetes in non-obese diabetic mice
    Mora, Adi
    Moog, Yoel
    Keren, Gad
    George, Jacob
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2009, 616 (1-3) : 301 - 305
  • [6] Identification of T helper type 1–like, Foxp3+ regulatory T cells in human autoimmune disease
    Margarita Dominguez-Villar
    Clare M Baecher-Allan
    David A Hafler
    Nature Medicine, 2011, 17 : 673 - 675
  • [7] No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes
    Brusko, Todd
    Wasserfall, Clive
    McGrail, Kieran
    Schatz, Richard
    Viener, Hina Lee
    Schatz, Desmond
    Haller, Michael
    Rockell, Jennifer
    Gottlieb, Peter
    Clare-Salzler, Michael
    Atkinson, Mark
    DIABETES, 2007, 56 (03) : 604 - 612
  • [8] BLIMP-1-dependent differentiation of T follicular helper cells into Foxp3+ T regulatory type 1 cells
    Garnica, Josep
    Yamanouchi, Jun
    Clarke, Robert
    Moro, Joel
    Thiessen, Shari
    Montano, Javier
    Mondal, Debajyoti
    Serra, Pau
    Santamaria, Pere
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [9] Preventative role of interleukin-17 producing regulatory T helper type 17 (Treg17) cells in type 1 diabetes in non-obese diabetic mice
    Bellemore, S. M.
    Nikoopour, E.
    Schwartz, J. A.
    Krougly, O.
    Lee-Chan, E.
    Singh, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2015, 182 (03): : 261 - 269
  • [10] Identification of T helper type 1-like, Foxp3+ regulatory T cells in human autoimmune disease
    Dominguez-Villar, Margarita
    Baecher-Allan, Clare M.
    Hafler, David A.
    NATURE MEDICINE, 2011, 17 (06) : 673 - 675